Abilify Maintena PMS in Schizophrenia Patients or Bipolar 1 Disorder
NCT03386851 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1030
Last updated 2022-02-14
Summary
This is a Post-Marketing Surveillance (PMS) of Abilify Maintena® Injections in accordance with Korean regulations on New Drug Re-examination (i.e. New Drug Re-examination Standards: Ministry of Food and Drug Safety(MFDS) Notification).
Conditions
- Schizophrenia
- Bipolar 1 Disorder
Sponsors & Collaborators
-
Korea Otsuka Pharmaceutical Co., Ltd.
lead INDUSTRY
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-13
- Primary Completion
- 2021-05-25
- Completion
- 2021-05-25
Countries
- South Korea
Study Locations
More Related Trials
-
Aripiprazole in Patients With Acute Mania
NCT00095511 ·Status: COMPLETED ·Phase: PHASE3
-
ABLE: Abilify in Bipolar Disorder for Long-term Effectiveness
NCT00484471 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
NCT06951698 ·Status: RECRUITING ·Phase: PHASE3
-
Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)
NCT01284218 ·Status: COMPLETED
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01822678 ·Status: COMPLETED ·Phase: PHASE2
-
Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)
NCT04812379 ·Status: COMPLETED
-
Aripiprazole Open-Label, Safety and Tolerability Study
NCT00102518 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
NCT02050854 ·Status: COMPLETED
-
A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
NCT03643159 ·Status: TERMINATED ·Phase: PHASE4
-
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT00606281 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolar I Disorder
NCT03854409 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine
NCT07185815 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Aripiprazole Once-Monthly in Hospitalized Patients (INITIATE)
NCT04907279 ·Status: UNKNOWN
-
A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
NCT00606229 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
NCT01122927 ·Status: TERMINATED ·Phase: PHASE3
-
Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania
NCT00488618 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Aripiprazole in Patients With a History of Bipolar Disorder
NCT00036348 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole in Late Life Bipolar Disorder
NCT00194038 ·Status: COMPLETED ·Phase: PHASE4
-
Lithium Versus Lamotrigine in Bipolar Disorder, Type II
NCT06184581 ·Status: RECRUITING ·Phase: PHASE4
-
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder
NCT00046384 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I Patients
NCT01567527 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
NCT04030143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
NCT07288320 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of Cariprazine for Bipolar I Disorder
NCT01058668 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder
NCT00036101 ·Status: COMPLETED ·Phase: PHASE3